首页> 外文期刊>Stem Cell Research & Therapy >Co-transplantation of mesenchymal stem cells improves spermatogonial stem cell transplantation efficiency in mice
【24h】

Co-transplantation of mesenchymal stem cells improves spermatogonial stem cell transplantation efficiency in mice

机译:间充质干细胞的共移植可改善小鼠精原干细胞的移植效率

获取原文
           

摘要

Spermatogonial stem cell transplantation (SSCT) could become a fertility restoration tool for childhood cancer survivors. However, since in mice, the colonization efficiency of transplanted spermatogonial stem cells (SSCs) is only 12%, the efficiency of the procedure needs to be improved before clinical implementation is possible. Co-transplantation of mesenchymal stem cells (MSCs) might increase colonization efficiency of SSCs by restoring the SSC niche after gonadotoxic treatment. A mouse model for long-term infertility was developed and used to transplant SSCs (SSCT, n?=?10), MSCs (MSCT, n?=?10), a combination of SSCs and MSCs (MS-SSCT, n?=?10), or a combination of SSCs and TGF?1-treated MSCs (MSi-SSCT, n?=?10). The best model for transplantation was obtained after intraperitoneal injection of busulfan (40?mg/kg body weight) at 4?weeks followed by CdCl2 (2?mg/kg body weight) at 8?weeks of age and transplantation at 11?weeks of age. Three months after transplantation, spermatogenesis resumed with a significantly better tubular fertility index (TFI) in all transplanted groups compared to non-transplanted controls (P??0.001). TFI after MSi-SSCT (83.3?±?19.5%) was significantly higher compared to MS-SSCT (71.5?±?21.7%, P?=?0.036) but did not differ statistically compared to SSCT (78.2?±?12.5%). In contrast, TFI after MSCT (50.2?±?22.5%) was significantly lower compared to SSCT (P??0.001). Interestingly, donor-derived TFI was found to be significantly improved after MSi-SSCT (18.8?±?8.0%) compared to SSCT (1.9?±?1.1%; P??0.001), MSCT (0.0?±?0.0%; P??0.001), and MS-SSCT (3.4?±?1.9%; P??0.001). While analyses showed that both native and TGF?1-treated MSCs maintained characteristics of MSCs, the latter showed less migratory characteristics and was not detected in other organs. Co-transplanting SSCs and TGF?1-treated MSCs significantly improves the recovery of endogenous SSCs and increases the homing efficiency of transplanted SSCs. This procedure could become an efficient method to treat infertility in a clinical setup, once the safety of the technique has been proven.
机译:精原干细胞移植(SSCT)可能成为儿童癌症幸存者的生育恢复工具。但是,由于在小鼠中,移植的精原干细胞(SSC)的定殖效率仅为12%,因此需要提高该过程的效率,然后才能进行临床实施。间充质干细胞(MSCs)的共移植可能通过性腺毒性治疗后恢复SSC的生态位而提高SSC的定殖效率。开发了用于长期不育的小鼠模型,并将其用于移植SSC(SSCT,n = 10),MSC(MSCT,n = 10),SSC和MSC的组合(MS-SSCT,n = 10)。 10),或SSC和TGFβ1处理过的MSC的组合(MSi-SSCT,n = 10)。最佳的移植模型是在4周时腹膜内注射白消安(40?mg / kg体重),然后在8周龄时使用CdCl2(2?mg / kg体重),并在11周时进行移植。年龄。移植后三个月,与未移植的对照组相比,所有移植组的精子发生恢复都显着好于肾小管生育指数(TFI)(P <0.001)。 MSi-SSCT后的TFI(83.3±±19.5%)显着高于MS-SSCT(71.5±±21.7%,P?= 0.036),但与SSCT(78.2±±12.5%)相比无统计学差异)。相反,MSCT后的TFI(50.2≤±22.5%)显着低于SSCT(P≤0.001)。有趣的是,与SSCT(1.9±±1.1%; P 0.001),MSCT(0.0±±0.0%)相比,MSi-SSCT(18.8±±8.0%)的供体来源TFI被显着改善。 ;P≤<0.001)和MS-SSCT(3.4≤±1.9%;P≤0.001)。尽管分析表明天然和经TGFβ1处理的MSC均保持了MSC的特征,但后者的迁移特征较少,在其他器官中未检测到。共移植SSC和经TGFβ1处理的MSC可显着提高内源性SSC的回收率,并提高移植的SSC的归巢效率。一旦该技术的安全性得到证实,该程序将成为治疗不孕症的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号